Function of mouse embryonic stem cell-derived supporting cells in neural progenitor cell maturation and long term expansion

PLoS One. 2013;8(1):e54332. doi: 10.1371/journal.pone.0054332. Epub 2013 Jan 14.

Abstract

Background: In the differentiation of mouse embryonic stem (ES) cells into neurons using the 5-stage method, cells in stage 4 are in general used as neural progenitors (NPs) because of their ability to give rise to neurons. The choice of stage 4 raises several questions about neural progenitors such as the type of cell types that are specifically considered to be neural progenitors, the exact time when these progenitors become capable of neurogenesis and whether neurogenesis is an independent and autonomous process or the result of an interaction between NP cells and the surrounding cells.

Methodology/principal findings: In this study, we found that the confluent monolayer cells and neural sphere like cell clusters both appeared in the culture of the first 14 days and the subsequent 6 weeks. However, only the sphere cells are neural progenitors that give rise to neurons and astrocytes. The NP cells require 14 days to mature into neural lineages fully capable of differentiation. We also found that although the confluent monolayer cells do not undergo neurogenesis, they play a crucial role in the growth, differentiation, and apoptosis of the sphere cells, during the first 14 days and long term culture, by secreted factors and direct cell to cell contact.

Conclusions/significance: The sphere cells in stage 4 are more committed to developing into neural progenitors than monolayer cells. Interaction between the monolayer cells and sphere cells is important in the development of stage 4 cell characteristics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Movement / physiology*
  • Cells, Cultured
  • Embryonic Stem Cells / cytology*
  • Mice
  • Neurons / cytology*
  • Stem Cells / cytology*

Grants and funding

This work was supported by a research grant from the High Level Talent Fund of the Beijing Healthcare System (Grant No: 2009-2-14, 2011-3-093), National Science Foundation of China (Grant No. 81272804; 30940039; 30970939), National Science Foundation of Beijing (Grant No. 7102078), Beijing Nova Program of Science and Technology (Grant No. 2009B22), Youth Foundation of Capital Medical University and Science Foundation of the Ministry of Education in China (Grant No. 11120066) and Key Project of Chinese Ministry of Education (Grant No. 210003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.